fbpx

Regeneron, Pfizer and BioNTech Accused of Infringing Allele Patent in Connection with COVID-19 TechnologiesBy: Rebecca Tapscotton October 7, 2020 at 11:15 am Publication: IPWatchdog.com | Patents & Patent Law

Allele Biotechnology and Pharmaceuticals, Inc. (Allele) has accused Regeneron Pharmaceuticals, Inc. (Regeneron); Pfizer, Inc. (Pfizer); and BioNTech SE and BioNTech US, Inc. (collectively BioNTech) for allegedly infringing U.S. Patent No. 10,221,221 (the ’221 patent), which is directed to an a  Read More>>

Categories   Courts, District Courts, IP News, IPWatchdog Articles, Licensing, Litigation, Patents, Technology & Innovation, Allele, Antibodies, biotechnology, COVID-19, intellectual property, patent, patent infringement, Patent Litigation, patents, Pfizer, Regeneron, vaccines

YouTube
LinkedIn
LinkedIn
Share